Maximum quantity allowed is 999
CAS RN: 4097-22-7 | Product Number: D3065
2',3'-Dideoxyadenosine
Purity: >98.0%(T)(HPLC)
- ddA
- 9-(2,3-Dideoxy-β-D-ribofuranosyl)adenine
Size | Unit Price | Same Day | 2-3 Business Days |
---|---|---|---|
100MG |
NT$18,840
|
16 | 10 |
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
Supplemental Product Information:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
Product Number | D3065 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__1__0H__1__3N__5O__2 = 235.25 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
CAS RN | 4097-22-7 |
Reaxys Registry Number | 619924 |
PubChem Substance ID | 87559802 |
SDBS (AIST Spectral DB) | 52173 |
Merck Index (14) | 3101 |
MDL Number | MFCD00010534 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
Melting point | 186.0 to 190.0 °C |
Specific rotation [a]20/D | -27.0 to -34.0 deg(C=1, H2O) |
NMR | confirm to structure |
Melting Point | 188 °C |
Specific Rotation | -34° (C=1,H2O) |
Pictogram | |
Signal Word | Warning |
Hazard Statements | H341 : Suspected of causing genetic defects. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
RTECS# | AU7358900 |
H.S.code* | 2940.00-000 |
References
- Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides
- Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro
- Metabolic pathways for the activation of the antiretroviral agent 2',3'-dideoxyadenosine in human lymphoid cells.
- Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivity
- Toxicity of Nucleoside Analogues Used to Treat AIDS and the Selectivity of the Mitochondrial DNA Polymerase (a review)
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.